Self-aggregation of the microtubule-binding protein Tau reduces its functionality and is tightly associated with Tau-related diseases, termed tauopathies. Tau aggregation is also strongly associated with two nucleating six-residue segments, namely PHF6 (VQIVYK) and PHF6* (VQIINK). In this paper, using experiments and computational modeling, we study the selfassembly of individual and binary mixtures of Tau fragments containing PHF6* (R2/ wt; 273 GKVQIINKKLDL 284 ) and PHF6 (R3/wt; 306 VQIVYKPVDLSK 317 ), and a mutant R2/ ΔK280 associated with a neurodegenerative tauopathy. The initial stage of aggregation is probed by ion-mobility mass spectrometry, the kinetics of aggregation monitored with Thioflavin T assays and the morphology of aggregates visualized by transmission electron microscopy. Insights into the structure of early aggregates and the factors stabilizing the aggregates are obtained from replica exchange molecular dynamics simulations. Our data suggest that R3/wt has a much stronger aggregation propensity than either R2/wt or R2/ΔK280. Heterodimers containing R3/wt are less stable than R3/wt homodimers but much more stable than homodimers of R2/wt and R2/ ΔK280, suggesting a possible role of PHF6*/PHF6 interactions in initiating the aggregation of full length Tau. Lastly, R2/ΔK280 binds stronger to R3/wt than R2/wt suggesting a possible mechanism for a pathological loss of normal Tau function. 
Introduction
Tau is a highly soluble, intrinsically disordered protein that normally binds to microtubules and regulates their dynamic growing and shortening behaviors. [1] [2] [3] In Alzheimer's disease (AD) and related neurodegenerative diseases, Tau dissociates from microtubules and selfassociates to form abnormal fibrillar aggregates. 4, 5 The distribution of these aberrant Tau structures is very well-correlated with neuronal cell death and the clinical progression of the diseases, suggesting an intimate link between aberrant Tau structure and neurodegeneration/ dementia (reviewed by Binder et al. 6 ). Recent efforts to identify the neurotoxic species of Tau have shifted focus away from mature, fibrillar aggregates toward smaller oligomeric Tau species. 7, 8 Studies with antibodies that selectively recognize Tau oligomers have demonstrated that these species are elevated in AD brains. [9] [10] [11] Cell to cell transmission of oligomeric Tau and other aberrant pre-fibrillar species may underlie the spread of Tau pathology, [12] [13] [14] [15] and these species show promise as potential therapeutic targets. 16, 17 A structural understanding of early Tau aggregates may lead to a deeper understanding of their neurotoxic mechanisms, as well as to the rational design of therapeutic drugs.
As a result of alternative RNA splicing there are 6 distinct isoforms of Tau that differ from one another depending upon the presence or absence of three inserts encoded by exons 2, 3 and 10 of the Tau gene ( Figure 1 ). There are two important domains in each Tau isoform: the N-terminal projection domain determines the inter-microtubule spacing between bundled microtubules and also mediates interactions of microtubules with plasma membrane. Exons 2 and 3 each encode 29-residue acidic inserts located in the N-terminal projection domain. In contrast, the microtubule binding pseudo-repreat (MTBR) domain contains either three or four imperfect repeats (depending upon the presence or absence of exon 10 encoded sequences) and serves to bind microtubules directly and to regulate their dynamics. 22 This same region of the protein makes up the core of fibrillar Tau aggregates, 23, 24 and Tau aggregation is accompanied by a regional transition from random coil to β-sheet structure.
Fibrillar Tau aggregates have a cross-β-structure typical of amyloid fibrils. Finally, the 6 tau isoforms differ from one another not only structurally but also in terms of the relative expression levels and their rates and extents of fibril formation. [18] [19] [20] [21] Genetic evidence demonstrates unequivocally that functional differences must exist among the 6 different tau isoforms.
Experimental aggregation studies, as well as computer simulations, have identified two important nucleating sequences within the MTBR, namely PHF6 (VQIVYK) and PHF6* (VQIINK). 26, 27 In vitro studies demonstrated that short Tau peptides containing PHF6 or PHF6* can form fibrillar aggregates. 28 PHF6 is located at the beginning of the third repeat and is present in all Tau isoforms. In contrast, PHF6* is located at the beginning of the second repeat and is present only in four-repeat (4R) Tau isoforms ( Figure 1 ) since it is encoded by alternatively spliced exon 10 sequences. PHF6* is the location of the ΔK280 mutation, which deletes the lysine present in PHF6* and causes a severe form of hereditary neurodegeneration. There are at least four additional disease-related mutants near these two hexapeptides that have been shown to induce more β-strand character, impair the ability of parallel β-sheets within the context of a fibril, and that two mating sheets come together with their hydrophobic side chains oriented inward to form a steric zipper. 30 A parallel β-sheet arrangement of the PHF6 segment within the fibrillar core is also supported by studies using solid state NMR 31 and electron paramagnetic resonance. 32 The latter technique revealed that the arrangement of the PHF6* segment can occupy a parallel β-sheet arrangement or a disordered arrangement, and that the parallel β-sheet arrangement is strongly promoted by the ΔK280 mutation. 33, 34 Previous work from our labs used a combination of computer simulations, ion mobility mass spectrometry (IM-MS), and transmission electron microscopy (TEM) to probe the structure and aggregation of a 12-amino acid peptide encompassing PHF6* and adjacent amino acids ("R2/wt", 273 GKVQIINKKLDL 284 ). 35 We found that the aggregation propensity of this peptide is related to the tendency of PHF6* to adopt an extended β-sheet conformation, with this tendency being stronger in the ΔK280 mutant ("R2/ΔK280", 273 GKVQIIN − KLDL 284 ) than in the wild-type (wt) peptide.
The PHF6 hexapeptide can self-aggregate even in the absence of the other peptides of Tau protein. 36 A computer simulation study 37 on the self-aggregation of the PHF6 fragment found a zipper-like arrangement of the amino acid residues owing to hydrophobic stabilization, similar to that reported by Sawaya et al. 30 On the other hand, structural models predict that the lysine in PHF6* makes interactions between PHF6-PHF6* unfavorable; 38 however, there is evidence that these sequences do interact. To identify PHF6 binding sequences, von Bergen and colleagues generated a library of overlapping Tau peptides immobilized on a membrane, and probed the membrane with a radio-labeled Tau fragment containing PHF6. Although binding was the strongest for peptides overlapping the PHF6 sequence, they also detected substantial binding to peptides overlapping the PHF6* sequence. 39 There is also evidence that these sequences interact during aggregation. Using short peptides corresponding to PHF6 and PHF6*, Moore and colleagues found evidence of direct PHF6-PHF6* interactions by circular dichroism and Thioflavin S (ThS) fluorescence under aggregating conditions. 40 While the former two studies employed short Tau peptides, there is also evidence for PHF6-PHF6* interactions in the context of large Tau fragments. In a fragment corresponding to the MTBR region of 4R Tau, insertion of a β-sheetdisrupting proline residue into either PHF6 or PHF6* was sufficient to suppress aggregation, as measured by ThS fluorescence and TEM. Interestingly, the inhibitory effect of a proline in the PHF6 sequence was overcome, and aggregation restored, by the presence of the ΔK280 mutation in the PHF6* sequence. 28 In an even longer tau fragment composed of the 4-repeat MTBR and C-terminal tail, Peterson and colleagues used NMR to probe Tau structure during aggregation, and found data consistent with a heterogeneous population of oligomeric species in which intermolecular interactions occur between PHF6-PHF6, PHF6*-PHF6*, and PHF6-PHF6*. 41 However, since mature Tau fibers show primarily parallel, in register β-sheet contacts between PHF6-PHF6 and PHF6*-PHF6*, [31] [32] [33] the role that PHF6-PHF6* interactions play at the early stages of aggregation is not clear.
In this paper, in order to shed new light on PHF6-PHF6* interactions, we study three individual tau peptides and their binary mixtures: R2/wt ( 273 GKVQIINKKLDL 284 , containing PHF6*), R3/wt ( 306 VQIVYKPVDLSK 317 , containing PHF6), and R2/ΔK280 ( 273 GKVQIIN−KLDL 284 ). A schematic of these three peptides is shown in Figure 1 , along with the full-length Tau isoform upon which the amino acid numbering convention is based. These fragments were originally designed and characterized by von Bergen et al., 28 and interactions between R2/wt-R2/wt and R2/ΔK280-R2/ΔK280 were previously studied with computer simulations and experiments by Larini et al. 35 In this present study, we focus on the homodimer of R3/wt, and heterodimers composed of R3/wt-R2/wt and R3/wt-R2/ ΔK280. Using a combination of experiments (IM-MS, Thioflavin T, and TEM) and replica exchange molecular dynamics (REMD) computer simulations, we investigate and compare the propensities of different peptide combinations to form oligomers. We probe the conformations of the stable oligomers, and the molecular mechanisms responsible for stabilization. We also discuss the effect of the ΔK280 mutation on PHF6-PHF6* interactions by comparing the results obtained with R2/wt and R2/ΔK280 peptides.
Materials and Methods

Sample preparation
The R2/wt, R2/ΔK280 and R3/wt peptides (> 98% purity) were purchased from Genscript Corp. (Piscataway, NJ), with N-and C-termini capped by acetylation and amidation, respectively. Fresh peptide powders were dissolved in water (HPLC grade; JT Baker) or 20 mM ammonium acetate buffer (pH = 7.0) to desired concentrations required for experiments.
Thioflavin T Assays and TEM
A stock solution of Thioflavin T (ThT; Anaspec) was prepared in 200 proof ethanol (Arcos Organics). Peptides stocks were prepared at 200 μM from lyophilized powder in 20 mM ammonium acetate buffer and then further diluted into the same buffer containing 2.2 μM ThT. Individual peptides were assayed at 50 μM (Supporting Information, Figure S1 ) and 25 μM. In binary mixtures, each peptide was present at 25 μM (50 μM total). The ThT response is linear under these conditions (Supporting Information, Figure S2 ). Following an initial "pre-heparin" measurement, heparin (Sigma, product H5515) was added to a final heparin to tau molar ratio of 1:4. Over the next 24 h, ThT fluorescence was monitored at 450ex/510em using a Wallac 1420 plate reader spectrofluorometer (PerkinElmer). After 24 h, samples of each aggregation mixture were removed and prepared for TEM. Briefly, samples were fixed in glutaraldehyde (1.6% final; Electron Microscopy Sciences), placed on 300-mesh formvarcarbon coated copper grids (Electron Microscopy Sciences), and then negatively stained with 2% uranyl acetate. Grids were imaged via a JEOL 1230 microscope equipped with an ORCA camera driven by AMT Image Capture Software (Version 5.24).
Ion Mobility Mass Spectrometry
Sample preparation-The peptide powders were dissolved in water to the concentration of 500 μM. Prior to IM-MS experiments, the stock solutions were diluted to 50 μM. For the binary mixtures of the peptides, the concentration of each peptide was 25 μM, so that the total peptide concentration was kept the same for all samples.
IM-MS experiments-
The IM-MS instrument was built in-house and consists of a nano-ESI source, an ion funnel, a 200-cm long drift cell and a quadrupole mass filter. 42 In the experiments, ions were generated through means of nano-ESI, stored in a source funnel and subsequently pulsed into a drift cell filled with helium gas at high pressure. The ions drift through the cell with a constant velocity due to the effects of a weak electrical field and a drag force resulting from the collisions with the buffer gas molecules. The arrival time distributions (ATDs) of mass-selected ions can be measured at different drift voltages, and subsequently used to determine the reduced mobility K 0 . The experimental cross sections of specific species can be calculated from K 0 after the oligomer size n and the charge z are assigned, as shown in Eq. 1 43,44 (1) where m and m b are the molecular weights of the ions and buffer gas molecules, respectively, ze is the charge of the ion, N is the buffer gas density and Ω avg is the average collision cross section integral, which approximates the average collision cross section σ.
Collision cross sections of theoretical structures obtained from simulations are computed using the Projection Approximation Method (PSA) available from http:// luschka.bic.ucsb.edu:8080/WebPSA/. 45, 46 
Molecular dynamics simulations
All-atomistic molecular simulations were performed using the GROMACS 4.5.5 package, 47 and a combination of the OPLS-AA [48] [49] [50] force field for protein and TIP3P 51 model for water. All the bonds of the peptide chains were constrained using the LINCS algorithm 52 and the water molecules were kept fully rigid using the SETTLE algorithm. 53 All the peptides were simulated in their natural charged states. The net positive charges on protein were neutralized with the addition of the chloride ions. The long range electrostatic interactions were calculated using the particle mesh Ewald method 54 with a grid spacing of 0.12 nm. The direct space cut-off radius for all nonbonded interactions was 1.2 nm. The Newtonian equations of motion were integrated using leap-frog integrator 55 with a time step of 2 fs. Molecular trajectories were sampled using replica exchange molecular dynamics (REMD) [56] [57] [58] scheme with canonical NVT ensemble. For the systems containing mixed R2 (R2/wt and R2/ΔK280) and R3/wt chains, a temperature range of 290 K to 450 K was sampled using 60 replicas. A temperature range of 290 K to 490 K was explored using 63 replicas for R3/wt homodimers. For every temperature used for exchanging the replicas, Nosé-Hoover thermostat 59,60 was used to keep the temperature constant. The replicas were exchanged every 3 ps with an average exchange probability of 20-25%. Trajectories were accumulated for 200-400 ns preceded by 100-150 ns of equilibration and the data obtained at 300 K were used for the analyses.
The conformations of the peptide chains were grouped by performing a cluster analysis based on the Daura algorithm. 61 The root mean square deviations (RMSD) of the peptide backbones were calculated and the conformations were grouped together if the RMSD of the peptide backbones were less than 0.26 nm compared to each other. Criteria for identifying a hydrogen bond were: (a) the distance between the oxygen and the hydrogen atom must be less than 0.25 nm and (b) the angle defined by oxygen-hydrogen-donor must be less than 30°. The end-to-end distance (R ee ) of the peptide chains were calculated by measuring the distance between the centers of mass of the acetylated and the amidated termini. The relative orientations of the monomers in a dimer were calculated by measuring the angles between the vectors connecting the alpha-carbons of V275 and K280 (for R2/wt), V275 and K281 (for R2/ΔK280), and I308 and V313 (for R3/wt). All the analyses were performed using the standard GROMACS tools.
Results and Discussion
R3/wt has a higher aggregation propensity than either R2/wt or R2/ΔK280
The mass spectra of R3/wt and the binary mixtures are shown in Figure 2 , panel A. Each peak is annotated with n/z where n is oligomer size and z is the charge. As seen in Figure  2A , in addition to the R3/wt monomer peak with a charge state z = +2, oligomers larger than trimers can be unambiguously observed in the mass spectrum and ion-mobility data. Ionmobility experiments reveal the existence of oligomers as large as octamers (see Supporting Information, Figure S3 ). The ATD of n/z = 2/3 contains multiple dimer features with compact to extended conformations (see also Figure 4A ). The ATD of n/z = 3/4 contains multiple trimer features. The ATD of n/z = 1/1 contains features corresponding to tetramer, hexamer and octamer. The assignment of the features is based on a combination of the isotropic model (which approximates the size of the globular oligomers) 62 and the arrival time differences between features under an assumption that the relative contribution of a monomer chain to the cross section decreases as the oligomer grows in size. The oligomer peaks in the mass spectra involving R3/wt peptides are significantly more intense than those of R2/wt and R2/ΔK280 obtained under the same condition (data not shown), suggesting that R3/wt is more prone to oligomerization than the other two peptides previously investigated. 35 However, the signal to noise (S/N) is high for high m/z species at longer incubation time, suggesting that there is not significant fibril formation as observed in selfaggregating, fibril formation peptides. 63 These results are in good agreement with the ThT assay, as elaborated below.
The kinetics of β-sheet oligomers and fibril formation in the first 6 hours in the presence and absence of heparin, a polyanionic compound that greatly stimulates Tau aggregation, is monitored with ThT assays (see Figure 3 and Supporting Information Figure S1 for 24-hour data). In the presence of heparin (panel A), R3/wt aggregates rapidly during which the kinetics show a rapid initial rise followed by a sigmoidal phase, and the ThT signal plateaus an order of magnitude higher than in the case of R2/wt or R2/ΔK280 (see Figure S1 , panel A). Of the latter two peptides, R2/ΔK280 shows the fastest aggregation. R2/wt aggregation is slower and follows a lag phase, but the ThT signal eventually reaches a higher plateau than in the case of the R2/ΔK280 mutant. In the absence of heparin (Figure 3, panel B) , only ThT signals of the R3/wt sample show a significant rise. However, since the maximum ThT intensity after 24 hours in the absence of heparin is only half of that in the presence of heparin (see Figure S1 ), and TEM imaging shows no abundant fibril formation of R3/wt without heparin (up to 50 μM, data not shown), we conclude that R3/wt fibril formation takes much longer than 24 hours. Within this time frame, only β-rich oligomers and protofibrils can be formed, which is also consistent with the detection up to octamer by IM-MS mentioned before.
R3/wt forms stable heterodimers with R2/wt and R2/ΔK280 suggesting possible interactions between the second and third repeats of full length Tau
We examine binary mixtures of R3/wt-R2/wt, R3/wt-R2/ΔK280, and R2/wt-R2/ΔK280 with IM-MS (see Figure 2B-D) . In all cases, mass spectral peaks corresponding to heterodimers are observed. We first consider the homo-and heterodimers of R2/wt and R2/ ΔK280, and use them as calibrants to better evaluate the stability of heterodimers containing R3/wt. A previous study 35 of R2/wt and R2/ΔK280 utilizing the same theoretical and experimental approach indicated that R2/ΔK280 supports a slightly better packing of homodimer configurations than R2/wt, due to the absence of a bulky, charged lysine. However, their homodimers are not significantly different in terms of stability. That conclusion is confirmed in the mass spectrum of the R2/wt and R2/ΔK280 mixture, in which the peak intensity ratio of homo-R2/ΔK280:heterodimer:homo-R2/wt is very close to 1:2:1 expected for statistical assembly. That is, heterodimers can exist in AB or BA configurations, as compared to a unique configuration AA or BB of the homodimers; therefore, the 1:2:1 ratio solely reflects that the possibility of dimer formation is twice the possibility for each homodimer to be formed, independently of structural stability. On the other hand, the corresponding ratios for binary mixtures containing R3/wt are not 1:2:1. They show a monotonic increase going from non-R3/wt homodimers, heterodimers to R3/wt homodimers. Therefore, the mass spectral data suggest that R3/wt homodimers are not only more stable than the homodimers of the other two peptides, but its heterodimers are also more favored to form than the R2/wt and R2/ΔK280 homodimers. This conclusion is in agreement with our REMD simulations showing that both R2 peptides form very stable dimers with R3/wt, even at ≈ 450K. For comparison, a dimer that contains only R2 peptides (either R2/wt or R2/ΔK280 homodimers) is stable up to ≈ 360K. 35 Furthermore, our simulation studies also show stable homodimer formation for R3/wt peptide at 490K (higher than that of the heterodimers). This result is in excellent agreement with the IM-MS and the ThT data, revealing the high aggregation propensity of R3/wt and stability of its homodimers over the heterodimers and R2/wt-containing homodimers.
The ATDs of the R3/wt homo-and heterodimer peaks are shown in Figure 4 . These data indicate that both R3/wt homo-and heterodimers can adopt both extended conformations (shown in red) and compact conformations (shown in blue). The extended conformations have higher populations, as shown by the intensities of the features at longer arrival times. Homodimers of R3/wt (panel A) contain a higher populations of extended structures than the two heterodimers (panels B-C). The experimental cross sections for the R3/wt homo-and heterodimers are in reasonably good agreement with those of the structures obtained from REMD simulations discussed below (see Figure S3 and Table S1 in the Supporting Information). Since no heteroligomers larger than dimer are observed, the competitive dimerization between R3/wt homo-and heterodimers may underlie an inhibition of R3/wt aggregation as observed by the ThT assays when R2/wt or R2/ΔK280 is present, as shown by comparing data in Figure 5 and Figure 3 (and also Figure S1 ).
The ThT signals of binary mixtures show that in each case aggregation is inhibited. The R2/wt-R2/ΔK280 mixture follows the same trends as R2/ΔK280 alone under the same condition (with or without heparin). However, the extent of R2/wt-R2/ΔK280 aggregation is less than R2/wt alone, despite the fact that the total peptide concentration in the binary mixture is twice as high.
R3/wt aggregation is in general inhibited in the presence of either R2 peptide. In detail, in the presence of heparin (panel A), the R3/wt-R2/ΔK280 mixture aggregates rapidly with two apparent phases, similar to R3/wt alone, but always at a lower level. The lag phases of aggregation are also prolonged. Aggregation in the R3/wt-R2/wt mixture is initially slower than R3/wt-R2/ΔK280 but reaches a high plateau. In the absence of heparin (panel B), R3/wt aggregation is completely suppressed by R2/ΔK280. In the absence of heparin, R3/wt aggregation is delayed by R2/wt, but eventually reaches the same plateau as in the case of pure R3/wt (see Figure 3, panel B) . The overall ThT data indicate that the interactions of R3/wt and R2 containing peptides are significant enough to slow down the aggregation. We conclude that R3/wt interacts more strongly with R2/ΔK280 than R2/wt (as shown in panel B), although the data in the presence of heparin (panel A) are ambiguous. Perhaps in the presence of heparin the aggregation kinetics are dominated by how each peptide interacts with heparin rather than their binary interactions. Figure 6 shows the fibril morphologies of individual peptides and their binary mixtures incubated for 24 hours in the presence of heparin. All samples populate fibrillar aggregates with diverse morphologies, including twisted fibers, ribbons, and bundles. Twisted fibrils are especially common for R2/wt whereas bundles are abundant in the case of R2/ΔK280. The formation of fibrils in R3/wt containing mixtures suggests that although the interactions of R3/wt with the other two peptides are strong, the inhibition effect is overcome by interactions with heparin and the preference of R3/wt oligomers over heteroligomers.
PHF6-PHF6 and PHF6-PHF6* interactions are stronger than PHF6*-PHF6* interactions: Molecular mechanism behind the stability Experiments indicate interactions containing R3/wt (i.e. PHF6) either with itself or R2/wt or R2/ΔK280 are favored. Consequently, we will focus on the R3/wt homo-and heterodimers in our REMD simulations. A cluster analysis based on the Daura algorithm 61 of the different peptide conformations suggests a wide range of possible dimer structures. Relevant representational conformations with significant populations are shown in Figure S4 in the Supporting Information. In order to analyze the structures and the conformations quantitatively we have plotted the distribution of the radius of gyration (R g ) of the dimers against the reduced end-to-end distance (R r ) of the dimers, where the reduced end-to-end distance of the dimers is defined as with R eeN being the end-to-end distance of the N-th chain. The corresponding conformational distributions are shown in Figure 7 . Panels A, B and C show the distributions of R g and R r for R2/wt-R3/wt, R2/ ΔK280-R3/wt and R3/wt-R3/wt dimers, respectively. The distributions of both compact and extended structures in the three systems are consistent with the ion-mobility data shown in Figure 4 . According to the simulation data, R2/ΔK280-R3/wt heterodimers predominantly prefer extended conformations (R g > 0.9 nm) with both peptide chains adopting strand-like structures (i.e. panel E showing both chains with R ee ≥ 3nm whereas the R2/wt-R3/wt heterodimers and the R3/wt homodimers explore both extended and compact conformations (R g < 0.9 nm), with R3/wt homodimers being relatively more ordered than R2/wt-R3/wt dimers (panels F vs. D). This observation is in good agreement with the experimental data suggesting that R2/ΔK280 is better at interacting with R3/wt to inhibit aggregation.
We also determined the relative orientations (parallel/anti-parallel vs. disordered) of the individual chains within a dimer with respect to each other by calculating the angles between the peptide chains as described in the method section. Heterodimers of R2/wt and R3/wt peptides, as plotted in Figure 8 , populate broader distributions between parallel (cosθ ≈ 1.0) and antiparallel (cosθ ≈ −1.0) conformations as compared to the R2/ΔK280-R3/wt and R3/wt-R3/wt dimers. The antiparallel orientations are slightly more preferred over the parallel conformations for both heterodimers. In contrast, R3/wt homodimers are much more ordered in terms of the relative orientations of the monomer chains, with parallel orientations preferred. For comparison, it can be mentioned that the dimers consisting of only R2 peptides show primarily antiparallel conformations. This preference was stronger in R2/wt homodimers than in R2/ΔK280 homodimers. 35 The effect of parallel vs. anti-parallel arrangements within β-rich oligomers on fibril formation has attracted attentions in recent years. In general, peptides that promote anti-parallel alignment tend to have slower aggregation kinetics than parallel-aligned peptides, supported by several classes of steric zipper x-ray structures solved by Eisenberg and co-workers. 30 The underlying phenomenon is that parallel alignment allows an easier matching between mating β-sheets to form a steric zipper, a type of oligomer that is crucial for fibril formation. Thus, the peptide chain alignment within R3/wt dimers (i.e. parallel) is consistent with its strong aggregation propensity, while that of R2/wt and R2/ΔK280 (i.e. anti-parallel) shows a less prone behavior.
The remaining question is whether R3/wt can access favorable interactions promoting oligomer formation that are not available to both R2 peptides. An insight from MD structural analysis reveals that the formation of multiple stable hydrogen bonds between the peptide chains promotes the stability of the dimers. Figure 9 , panels A-C show the distributions of the number of the hydrogen bonds between the peptide monomers for R2/wt-R3/wt, R2/ΔK280-R3/wt, and R3/wt-R3/wt dimers respectively. R3/wt peptides form four or more hydrogen bonds with R2/wt, R2/ΔK280 and R3/wt peptides in more than 85%, 90%, and 95% of the total dimer structures respectively. In comparison, R2 peptide homodimers form four or more hydrogen bonds in 10-20% of the dimer structures. 35 We also performed a detailed analysis of the formation of hydrogen bonds between individual amino acid residues. The results are plotted in terms of the percentage of the total simulation time in Figure 9 , panels D-F. From these plots, we can see that the pattern of hydrogen bonding is the most ordered in R3/wt homodimers, and the least ordered in R2/wt-R3/wt heterodimers, with R2/ΔK280-R3/wt heterodimers intermediate. It can be inferred that the PHF6 fragment in the R3/wt peptide plays a prominent role in the formation of stable hydrogen bonds, and interacts preferentially with the PHF6* fragments in the heterodimers and with the PHF6 fragment in the homodimer. The total number of PHF6-PHF6 hydrogen bonds is higher than that for PHF6-PHF6*. The number of the hydrogen bonds between PHF6 and PHF6* contributes to the 49% of the total hydrogen bonds formed between R3/wt and R2/wt and and 57% between R3/wt and R2/ΔK280 peptides. PHF6-PHF6 hydrogen bonds contribute 59% of the total hydrogen bonds found in R3/wt homodimers. From Figure 9 , panel F it is clear that the major R3/wt residues involved in hydrogen bonding are the glutamine (Q307), valine (V309), and lysine (K311) located within the PHF6 fragment. Preferential hydrogen bonding between PHF6-PHF6 and PHF6-PHF6* positions the hydrophobic sections of both peptides in close proximity. In addition, charges of opposite signs are generally close to each other in R3/wt containing dimers, adding to their stability. Furthermore, the C-H π interaction between isoleucine (I308) and tyrosine (Y310) is an essential factor contributing to the formation of the dry interface of the steric zipper oligomers. 36, 64 Thus the dimers involving R3/wt peptide are more stable and ordered than the dimers composed of R2 peptides only. Comparing the two heterodimers, R3/wt-R2/ΔK280 dimers show more stability and order than R3/wt-R2/wt dimers. Homodimers composed of R2/wt chains position lysines K280 and K281 (located near the middle of the peptide) in close contact, and the resulting electrostatic repulsion destabilizes the dimer. Whereas this problem is not as prominent in the case of R2/ΔK280 homodimers.
Summary and Conclusions
We have used a variety of complementary experimental and computer simulation methods to study the interactions between PHF6 and PHF6* in the context of the short Tau peptides R3/wt, R2/wt, and R2/ΔK280. The main conclusions can be summarized as follows:
• R3/wt forms fibrillar aggregates more readily than the R2/wt or R2/ΔK280 peptides.
• The presence of either of the R2 peptides inhibits R3/wt aggregation. The R3/wt fragment binds stronger to R2/ΔK280.
• R3/wt prefers to form R3/wt-R3/wt homodimers, but also forms stable heterodimers of R3/wt-R2/wt and R3/wt-R2/ΔK280. The heterodimers containing R3/wt are more stable than R2/wt and R2/ΔK280 homodimers. In contrast, R2/wt-R2/ΔK280 heterodimers are comparable in stability to their homodimers.
• R3/wt homodimers prefer parallel conformations stabilized by PHF6-PHF6 hydrogen bonds and hydrophobic contacts. Heterodimers of R3/wt-R2/wt and R3/wt-R2/ΔK280 are less ordered in comparison, populating both parallel and antiparallel arrangements, and are stabilized by PHF6-PHF6* interactions. Of the two heterodimers, R3/wt-R2/wt are the least ordered, due to the disruptive influence of K280. Parallel alignment supports the strong aggregation propensity of R3/wt.
Taken together, our data strongly indicate the importance of PHF6, which is present in both 3R and 4R tau, as the major nucleating sequence driving Tau aggregation. PHF6 is found to play a dominant role over PHF6* (which is present in only 4R Tau) in terms of initiating and stabilizing the Tau aggregates. We suggest that this dominance is due to the strong tendency of the PHF6 sequence to populate ordered dimers with a parallel arrangement, even in the absence of aggregation inducers. In this experimental system, we find that although PHF6-PHF6* readily interact, they result in less ordered dimer conformations than PHF6-PHF6 interactions, and are less favorable toward aggregation. It has been shown that for 3R and 4R Tau with the same N-terminal projection domain, 4R isoforms often have lower critical concentration and shorter lag time for aggregation. Interestingly, 4R Tau isoforms have been shown to drive aggregation of 3R Tau, 65 as well as 3R Tau isoforms can seed aggregation of 4R Tau, 66 suggesting possible interactions between heterotypic aggregation prone segments within 4R and 3R, in which PHF6 and PHF6* are the two strongest candidates. Our data unambiguously strengthen this hypothesis, as the interactions can become more favorable when both segments are present in the same protein sequence (for example, by promoting a favorable arrangement of the intervening and surrounding sequences). Our data support models in which many structural rearrangements accompany the transition from dimers and early oligomers to mature fibers. 37 Molecular mechanisms behind the interactions involving PHF6 and PHF6*, as inferred from our results, can potentially explain the physical nature of the aggregation of full-length 3R and 4R Tau proteins. Furthermore, the strong binding between R3/wt with disease related ΔK280 mutant implies a possible toxicity mechanism, as the tight complexes of PHF6 containing Tau and the ΔK280 mutant could reduce the population of functional Tau available to regulate microtubule dynamics and/or to promote pathological trans-synaptic tau transfer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. nano-ESI mass spectra of (A) R3/wt and the binary mixtures of (B) R3/wt and R2/wt, (C) R3/wt and R2/ΔK280, and (D) R2/wt and R2/ΔK280 at 50 μM total peptide concentration. The peaks are annotated with n/z where n is the oligomer size and z is the charge. n is labeled in black, blue and red for the species corresponding to R3/wt, R2/wt, and R2/ΔK280 respectively. The insets in panels B-D show the relative abundance of heterodimers vs. homodimers in each binary mixture. Thioflavin T assays reveal differences in the extent and kinetics of aggregation between the individual peptides. R2/wt, R2/ΔK280, and R3/wt peptides were incubated separately at 50 μM in buffer containing ThT, with (A) or without (B) heparin over the first 6 h. Data shown are the average of three independent trials ±SEM. 
